Position in GILD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$21,841,369
-$55,464,087 QoQ
Shares Held
156,715
-75.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2026CallValue
$34,842,500
CallShares
250,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIXIS holds $547,855,762 across 11 Drug Manufacturers - General names. GILD ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
2,068,064 | $125,428,081 | |
| 2 | LLY |
ELI LILLY & Co
|
100,947 | $92,848,022 | |
| 3 | NVO |
Novo Nordisk A S
|
2,005,285 | $73,694,223 | |
| 4 | MRK |
Merck & Co., Inc.
|
510,056 | $61,354,636 | |
| 5 | PFE |
Pfizer Inc
|
1,912,234 | $53,695,530 | |
| 6 | JNJ |
Johnson & Johnson
|
213,825 | $52,267,383 | |
| 7 | ABBV |
AbbVie Inc.
|
233,196 | $50,717,798 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
156,715 | $21,841,369 |
All Filings in GILD
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,841,369 | 156,715 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $34,842,500 | 250,000 | Call | Sole | 2026-05-14 | |
| 2025-12-31 | $77,305,456 | 629,831 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $75,084,840 | 676,440 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $42,214,085 | 380,753 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $29,569,098 | 263,892 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $24,957,819 | 270,194 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $33,665,197 | 401,541 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $22,694,266 | 330,772 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,150,554 | 152,226 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $8,774,193 | 108,310 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $26,623,559 | 355,265 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $46,555,289 | 604,065 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $55,600,354 | 670,126 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $43,753,881 | 509,655 | Shares | Sole | 2023-02-24 | |
| 2022-12-31 | $1,717,000 | 20,000 | Put | Sole | 2023-02-24 | |
| 2022-09-30 | $65,317,063 | 1,058,795 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $1,233,800 | 20,000 | Put | Sole | 2022-11-14 | |
| 2022-06-30 | $52,193,600 | 844,420 | Shares | Sole | 2022-08-12 | |
| 2022-06-30 | $2,714,262 | 43,913 | Put | Sole | 2022-08-12 | |
| 2022-03-31 | $134,006,245 | 2,254,100 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $29,123,870 | 401,100 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,445,832 | 235,445 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $103,210,190 | 1,498,841 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $67,316,604 | 1,041,569 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $77,633,780 | 1,332,540 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $59,808,260 | 946,483 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $23,777,229 | 309,036 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,666,175 | 22,287 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||